India to Philippines: Lapatinib Export Trade Route

The India to Philippines Lapatinib corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $120.7K USD. The route is dominated by BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's lapatinib manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $17.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with lapatinib's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 17.0%, placing it at rank #18 among India's top lapatinib export destinations globally.

On the import side, key buyers of Indian lapatinib in Philippines include AMINCORP, ELEV8 CONSUMER GOODS TRADING. AMINCORP is the single largest importer with 5 shipments valued at $119.5K USD.

India's lapatinib exports to Philippines are driven primarily by a handful of large-scale manufacturers. BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, MALLESHWAR SPECIALITIES — together account for 100% of total trade value on this route. The average shipment value of $17.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as lapatinib (as ditosylate monohydrate) 250mg film coated tab (lapaheal)(tax inv# mh2411600497 dt:17.01.2025)(o and lapatinib as distosylate monohydrate 2, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AMINCORP is the largest importer with 5 shipments worth $119.5K USD — representing 99% of all lapatinib imports from India on this route.